Integrated Filing — IndAS



General information about company
Scrip Code 000000
NSE Symbol AMBANIORGO
MSEI Symbol NOTLISTED
ISIN INE00C501018
Name of company AMBANI ORGOCHEM LIMITED
Type of company SME
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 29-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 26-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Half Yearly
Reporting Quarter Yearly
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products
Start date and time of board meeting 29-May-2025   15:30:00
End date and time of board meeting 29-May-2025   18:30:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2025-03-31
Indicate Company website link for updated RPT policy of the Company www.ambaniorgochem.com
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Not Applicable



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Oct-2024 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 1107841000 1925387000
Other income 11751000 13888000
Total income 1119592000 1939275000
2 Expenses
(a) Cost of materials consumed 921065000 1569946000
(b) Purchases of stock-in-trade 0 0
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -98568000 -106139000
(d) Employee benefit expense 39788000 76946000
(e) Finance costs 34374000 77762000
(f) Depreciation, depletion and amortisation expense 15774000 30365000
(f) Other Expenses
1 Other Expenses 194643000 291678000
Total other expenses 194643000 291678000
Total expenses 1107076000 1940558000
3 Total profit before exceptional items and tax 12516000 -1283000
4 Exceptional items 4875000 0
5 Total profit before tax 17391000 -1283000
6 Tax expense
7 Current tax 8515000 12800000
8 Deferred tax 0 0
9 Total tax expenses 8515000 12800000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 8876000 -14083000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 8876000 -14083000
17 Other comprehensive income net of taxes 0 0
18 Total Comprehensive Income for the period 8876000 -14083000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 76587000 76587000
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve 406894000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.35 -2.21
Diluted earnings (loss) per share from continuing operations 0.36 -2.2
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.35 -2.21
Diluted earnings (loss) per share from continuing and discontinued operations 0.36 -2.2
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 813502000
Capital work-in-progress 0
Investment property 0
Goodwill 0
Other intangible assets 0
Intangible assets under development 0
Biological assets other than bearer plants 0
Investments accounted for using equity method 0
Non-current financial assets
Non-current investments 13408000
Trade receivables, non-current 0
Loans, non-current 11585000
Other non-current financial assets 14741000
Total non-current financial assets 39734000
Deferred tax assets (net) 0
Other non-current assets 0
Total non-current assets 853236000
2 Current assets
Inventories 412683000
Current financial asset
Current investments 0
Trade receivables, current 422178000
Cash and cash equivalents 161958000
Bank balance other than cash and cash equivalents 0
Loans, current 5841000
Other current financial assets 223162000
Total current financial assets 813139000
Current tax assets (net) 0
Other current assets 0
Total current assets 1225822000
3 Non-current assets classified as held for sale 0
4 Regulatory deferral account debit balances and related deferred tax Assets 0
Total assets 2079058000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 133491000
Other equity 435244000
Total equity attributable to owners of parent 568735000
Non controlling interest
Total equity 568735000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 217018000
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0
Total Trade payable 0
Other non-current financial liabilities 74878000
Total non-current financial liabilities 291896000
Provisions, non-current 0
Deferred tax liabilities (net) 907000
Deferred government grants, Non-current 0
Other non-current liabilities 0
Total non-current liabilities 292803000
Current liabilities
Current financial liabilities
Borrowings, current 322452000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 375236000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 477706000
Total Trade payable 852942000
Other current financial liabilities
Total current financial liabilities 1175394000
Other current liabilities 30489000
Provisions, current 11637000
Current tax liabilities (Net) 0
Deferred government grants, Current 0
Total current liabilities 1217520000
3 Liabilities directly associated with assets in disposal group classified as held for sale 0
4 Regulatory deferral account credit balances and related deferred tax liability 0
Total liabilities 1510323000
Total equity and liabilites 2079058000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Oct-2024 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Oct-2024 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
Total Amount of items that will not be reclassified to profit and loss
2 Income tax relating to items that will not be reclassified to profit or loss
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income



Cash flow statement, indirect
Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax -1283000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 0
Adjustments for decrease (increase) in inventories -120881000
Adjustments for decrease (increase) in trade receivables, current -155778000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets 15907000
Adjustments for decrease (increase) in other non-current assets -644000
Adjustments for other financial assets, non-current 976000
Adjustments for other financial assets, current -1922000
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current 289755000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities -10577000
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 30365000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current 2606000
Adjustments for provisions, non-current -3784000
Adjustments for other financial liabilities, current 0
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains 0
Adjustments for dividend income 0
Adjustments for interest income 11472000
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) 0
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) -801000
Other adjustments for non-cash items 0
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) 33750000
Net cash flows from (used in) operations 32467000
Dividends received 0
Interest paid -77762000
Interest received 0
Income taxes paid (refund) 2017000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities 108212000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 0
Purchase of property, plant and equipment 200997000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 11472000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 204863000
Net cash flows from (used in) investing activities 15338000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 63800000
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 4368000
Repayments of borrowings 15522000
Payments of lease liabilities 0
Dividends paid 0
Interest paid 77762000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities -25116000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 98434000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents 98434000
Cash and cash equivalents cash flow statement at beginning of period 63524000
Cash and cash equivalents cash flow statement at end of period 161958000





Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 SHAMBHU GUPTA & CO. Yes 30-Nov-2025


Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)
Mode of Fund Raising Preferential Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 20-Feb-2025
Amount Raised 2835000000000
Report filed for Quarter ended 31-Mar-2025
Monitoring Agency Not Applicable
Monitoring Agency Name, if applicable
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation NOT APPLICABLE
Comments of the Audit Committee after review NIL
Comments of the auditors, if any NIL
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 a) Meet working capital requirements and expand the existing business of the Company.nb) General corporate purposes or such other objects, as the board may from time to timendecide in the best interest of the Company. NIL 2835000000000 0 2835000000000 0


Signatory Details
Name of signatory RAKESH SHAH
Designation of person Managing Director
Place MUMBAI
Date 29-May-2025




Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Mr. Rakesh Shah Ambani Orgochem Limited Director Remuneration 2400000 0 6850000 33134000 0 Loan 0 1 year
2 Mrs. Apooni Shah Ambani Orgochem Limited Director Remuneration 2400000 0 619000 418000 0 Loan 0 1 year
3 Mr. Sharad Kothari Ambani Orgochem Limited Relative of Key Management/ Associate Remuneration 90000 0 0 0 0
4 Mr Aashay R Shah Ambani Orgochem Limited Relative of Key Management/ Associate Remuneration 2050000 0 1060000 3135000 0 Loan 0 1 year
5 Mr. Bhavesh Pandya Ambani Orgochem Limited CFO Remuneration 379000 0 0 0 0
6 Mr. Paresh Shah Ambani Orgochem Limited CEO Remuneration 366000 0 0 0 0
7 Mrs. Neha Shah Ambani Orgochem Limited Relative of Key Management/ Associate Remuneration 303000 0 0 0 0
8 Ms. Richa Chokhani Ambani Orgochem Limited CS Remuneration 0 0 0 0 0
9 Ms. Vannie Dangi Ambani Orgochem Limited CS Remuneration 180000 0 0 0 0
10 Mr. Bhavin Patel Ambani Orgochem Limited Director Remuneration 452000 0 0 0 0
11 Mr. Neerajkumar Pandey Ambani Orgochem Limited Director Remuneration 617000 0 0 0 0
12 Omega Woven Mills Pvt Ltd Ambani Orgochem Limited Subsidiary Company Advance 0 0 0 0 0
13 Om Maruti Glasswool & Wirenetting Products Pvt Ltd Ambani Orgochem Limited Subsidiary Company Advance 0 0 64000 0 0
14 Omega Woven Mills Pvt Ltd Ambani Orgochem Limited Subsidiary Company Any other transaction Rent 0 0 300000 0 0
15 Om Maruti Glasswool & Wirenetting Products Pvt Ltd Ambani Orgochem Limited Subsidiary Company Any other transaction Rent 0 0 300000 0 0
Total value of transaction during the reporting period 9193000